Pharmena S.A. (WSE:PHR)

Pharmena Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	May 13, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	48	79	62	88	99	59
Market Cap Growth	-4.68%	26.79%	-29.20%	-10.89%	67.91%	0.67%
Enterprise Value	37	57	72	96	103	60
Last Close Price	4.30	6.41	5.05	7.14	8.12	4.84
PE Ratio	-	2.73	-	-	-	-
Forward PE	-	26.88	26.88	26.88	26.88	26.88
PS Ratio	155.49	264.48	208.60	5.79	9.95	5.31
PB Ratio	4.08	3.56	-9.18	-17.20	-284.09	11.79
P/TBV Ratio	4.14	3.53	-	-	-	13.60
P/FCF Ratio	-	2.42	39.15	-	-	-
P/OCF Ratio	-	2.39	34.29	-	-	-
EV/Sales Ratio	120.93	191.28	241.50	6.34	10.39	5.44
EV/EBITDA Ratio	-	1.74	-	-	-	-
EV/EBIT Ratio	-	1.74	-	-	-	-
EV/FCF Ratio	-12.49	1.75	45.33	-	-	-
Debt / Equity Ratio	0.01	0.01	-1.49	-1.90	-15.83	0.70
Debt / EBITDA Ratio	-	0.01	-	-	-	-
Debt / FCF Ratio	-	0.01	6.37	-	-	-
Asset Turnover	0.02	0.02	0.03	1.38	0.88	1.20
Inventory Turnover	0.06	0.05	0.04	1.82	0.91	1.16
Quick Ratio	15.77	12.84	0.30	0.40	0.37	0.63
Current Ratio	16.64	13.17	0.59	0.71	0.74	1.27
Return on Equity (ROE)	-9.79%	350.10%	-	-	-299.40%	-276.20%
Return on Assets (ROA)	-10.94%	111.71%	-21.39%	-22.93%	-33.80%	-69.06%
Return on Capital (ROIC)	-12.05%	159.20%	-63.94%	-51.97%	-56.21%	-111.50%
Return on Capital Employed (ROCE)	-	146.70%	-	-	-	-
Earnings Yield	-3.38%	36.60%	-2.52%	-5.21%	-6.97%	-16.02%
FCF Yield	-6.22%	41.37%	2.55%	-4.02%	-2.48%	-22.79%
Dividend Yield	19.77%	13.27%	-	-	-	-
Buyback Yield / Dilution	-	-	-0.25%	-1.25%	-9.87%	-13.85%
Total Shareholder Return	19.77%	13.27%	-0.25%	-1.25%	-9.87%	-13.85%

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.